|
|
|
|
Within the next few months, researchers at three medical centers expect to start the first test in patients of one of the most promising — and contentious — ideas about the cause and treatment of cancer.
The idea is to take aim at what some scientists say are cancerous stem cells — aberrant cells that maintain and propagate malignant tumors.
|
|
|
|
|
|
|
No link or resource associated with this scan
|
|
|
|
|